GE iIn Vitro Toxicology Testing Products Reviews & Features

Are you from this Company?
GE
Massachusetts, USA
1892
More than $100 BN
Enterprise
83 Likes
74 Buyers Negotiating

Summary

The models offered by GE are used to study the cardiotoxic effects of lead molecules at an early phase of drug discovery. Cardiomyocytes provide a sensitive and robust approach for screening new chemical entities for potential cardiotoxic liabilities and gaining early insight into their mechanisms of toxicity. It focuses on developing innovative human cell-based assays and models to assist drug discovery and predictive toxicity screening.

Discussions

Strengths
  • +13
    GLP/Manufacturing excellence practices
  • +8
    Pharmaceuticals and Biotechnology
  • +14
    Cell culture technology
  • +14
    IVTT Assays
  • +5
    Highthroughput screening
  • +6
    Cellular imaging
  • +11
    Cytotoxicity
  • +7
    Focus on Product Innovation
  • +6
    Product Quality and Reliability
  • +8
    Product Differentiation and Impact on Customer Value
  • +5
    Breadth and Depth of Product Offerings
  • +8
    ADME
  • +9
    Cosmetics
  • +5
    IVTT Services
  • +9
    Skin irritation
  • +10
    Genotoxicity
  • +10
    Food
  • +6
    IVTT Reagents
  • +11
    Chemical
  • +7
    Toxicogenomics
Cautions
  • -12
    Other products
I agree to 360Quadrants Terms of use and privacy policy
Success
info
Error
Company Size :
  Enterprise
  SME
  Startup